4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ImageneBio, Inc. (IMA) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 17 employees. Its market capitalization is roughly $68 million. In the fiscal year ended 2025-12-31, IMA reported $1M in revenue and ($45M) in net income.
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $1M | $4M | $8M |
| Operating Income (EBIT) | ($48M) | ($37M) | ($22M) |
| Net Income | ($45M) | ($37M) | ($21M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $0M |
| Operating Income (EBIT) | ($12M) | ($8M) | ($27M) | ($6M) | ($6M) |
| Net Income | ($11M) | ($7M) | ($25M) | ($6M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $153M | $16M | $31M |
| Total Liabilities | $20M | $176M | $157M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IMA viewer.
About TickerBase · Data methodology & sources